Prevention

114 drugs in development·73 companies·1 clinical trial

Drug Pipeline by Phase

Approved(59)

Drug	Company
acam2000	Emergent BioSolutions Inc. (EBS)
acetazolamide	Prestige Consumer Healthcare Inc. (PBH)
acetazolamide	MANNKIND CORP (MNKD)
acetazolamide	Greenwich LifeSciences, Inc. (GLSI)
acetazolamide	ACHIEVE LIFE SCIENCES, INC. (ACHV)
acetazolamide	ACADIA PHARMACEUTICALS INC (ACAD)
alendronate	Mylan II B.V. (MYL)
aponvie	HERON THERAPEUTICS, INC. /DE/ (HRTX)
aprepitant	Mylan II B.V. (MYL)
arakoda	60 DEGREES PHARMACEUTICALS, INC. (SXTP)
bevyxxa	PORTOLA PHARMACEUTICALS INC (PTLA)
bupropion	Prestige Consumer Healthcare Inc. (PBH)
bupropion	Impax Laboratories, LLC (IPXL)
bupropion	Design Therapeutics, Inc. (DSGN)
bupropion	AlphaTON Capital Corp (ATON)
Capvaxive	Merck & Co., Inc. (MRK)
cinvanti	HERON THERAPEUTICS, INC. /DE/ (HRTX)
collaguard	INNOCOLL HOLDINGS PLC (INNL)
collatampg	INNOCOLL HOLDINGS PLC (INNL)
dipyridamole	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
Emgality	ELI LILLY & Co (LLY)
Emgality®	ELI LILLY & Co (LLY)
enflonsia	Merck & Co., Inc. (MRK)
Ervebo	Merck & Co., Inc. (MRK)
exforge hct	Novartis AG (NVS)
extended phenytoin	SUNSET ISLAND GROUP (SUN)
fosphenytoin	Amneal Pharmaceuticals, Inc. (AMRX)
granisetron	Amneal Pharmaceuticals, Inc. (AMRX)
granisetron	Sana Biotechnology, Inc. (SANA)
heparin	PFIZER INC (PFE)
isosorbide mono	EXELIXIS, INC. (EXEL)
ixinity	XOMA Royalty Corporation (XOMA)
losartan	Teva Pharmaceutical Industries Limited (TEVA)
magnesium	EXELIXIS, INC. (EXEL)
medroxyprogesterone	Amphastar Pharmaceuticals, Inc. (AMPH)
mRESVIA	Moderna, Inc. (MRNA)
nebivolol	ANI PHARMACEUTICALS INC (ANIP)
Nexplanon	Organon & Co. (OGN)
Noxafil	Merck & Co., Inc. (MRK)
NuvaRing	Organon & Co. (OGN)
olmesartan medoxomil	Amneal Pharmaceuticals, Inc. (AMRX)
palonosetron	Teva Pharmaceutical Industries Limited (TEVA)
pemgarda	Invivyd, Inc. (IVVD)
phexx	Evofem Biosciences, Inc. (EVFM)
phexxi	Evofem Biosciences, Inc. (EVFM)
prehevbrio	VBI VACCINES INC/BC (VBIV)
progesterone	DR REDDYS LABORATORIES LTD (RDY)
ryanodex	EAGLE PHARMACEUTICALS, INC. (EGRX)
septocoll	INNOCOLL HOLDINGS PLC (INNL)
sumatriptan	Mylan II B.V. (MYL)
sustol	HERON THERAPEUTICS, INC. /DE/ (HRTX)
telmisartan	Inventiva S.A. (IVA)
thalomid	CELGENE CORP /DE/ (CELG)
tiopronin	Amneal Pharmaceuticals, Inc. (AMRX)
ursodiol	Optec International, Inc. (GM)
varubi	TESARO, Inc. (TSRO)
vazalore	PLX PHARMA INC. (DPRX)
VIVITROL	Alkermes plc. (ALKS)
yutiq	ALIMERA SCIENCES INC (ALIM)

Phase 3(8)

Drug	Company
AR-320	Aridis Pharmaceuticals, Inc. (ARDS)
CD388	Cidara Therapeutics, Inc. (CDTX)
d961h	ASTRAZENECA PLC (AZN)
expec9v	GH Research PLC (GHRS)
inclisiran sodium 300 mg in	Novartis AG (NVS)
jnp-0301	JUNIPER PHARMACEUTICALS INC (JNP)
nereus	Vanda Pharmaceuticals Inc. (VNDA)
posoleucel	Kalaris Therapeutics, Inc. (KLRS)

Phase 2(13)

Drug	Company
amphora	PDL BIOPHARMA, INC. (PDLI)
at-1501	Eledon Pharmaceuticals, Inc. (ELDN)
High dose antigen of LYB005 with A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
High dose antigen of LYB005 without A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
Low dose antigen of LYB005 with A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
Low dose antigen of LYB005 without A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
Middle dose antigen of LYB005 with A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
Middle dose antigen of LYB005 without A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
prv-3279	PROVENTION BIO, INC. (PBI)
rF1V (plague vaccine)	DYNAVAX TECHNOLOGIES CORP (DVAX)
rF1V-1018	DYNAVAX TECHNOLOGIES CORP (DVAX)
rF1V-1018	UNITED THERAPEUTICS Corp (UTHR)
rlyb212	Rallybio Corp (RLYB)

Phase 1(5)

Drug	Company
Anti-Viral Veto Cell	Cell Source, Inc. (CLCS)
Breast cancer vaccine (alpha-lactalbumin)	Anixa Biosciences Inc (ANIX)
db-020	Decibel Therapeutics, Inc. (DBTX)
SER-147	Seres Therapeutics, Inc. (MCRB)
VRC-FLUMOS0116-00-VP	Cidara Therapeutics, Inc. (CDTX)

Preclinical(16)

Drug	Company
AMHR2-ED ovarian cancer vaccine	Anixa Biosciences Inc (ANIX)
AR-201	Aridis Pharmaceuticals, Inc. (ARDS)
civax	SOLIGENIX, INC. (SNGX)
fmd vaccine	GENVEC INC (GNVC)
hsv vaccine	GENVEC INC (GNVC)
ipoxyn	NANOMIX CORP (BTHI)
kb174	Kaleido Biosciences, Inc. (KLDO)
mam01/atrc-501	Atreca, Inc. (BCEL)
nm-003	9 METERS BIOPHARMA, INC. (NMTR)
prv-101	PROVENTION BIO, INC. (PBI)
rsv vaccine	GENVEC INC (GNVC)
SG-001	ADMA BIOLOGICS, INC. (ADMA)
Vaccine discovery program (additional cancer vaccines)	Anixa Biosciences Inc (ANIX)
vax-xl	Vaxcyte, Inc. (PCVX)
vby329	Invivyd, Inc. (IVVD)
vybrin	Vicapsys Life Sciences, Inc. (VICP)

Unknown(3)

Drug	Company
HLX14	Organon & Co. (OGN)
Mediterranation®	Cosmos Health Inc. (COSM)
Sky Premium Life (SPL)	Cosmos Health Inc. (COSM)

BLA Filed(1)

Drug	Company
eptinezumab	ALDER BIOPHARMACEUTICALS INC (ALDR)

Early Phase 1(1)

Drug	Company
VTP-500	Barinthus Biotherapeutics plc. (BRNS)

Phase 2/Phase 3(4)

Drug	Company
adintrevimab	Invivyd, Inc. (IVVD)
belapectin	GALECTIN THERAPEUTICS INC (GALT)
hil-216	HilleVax, Inc. (HLVX)
tecarfarin	Cadrenal Therapeutics, Inc. (CVKD)

Phase 4(4)

Drug	Company
High dose potent statin	Cidara Therapeutics, Inc. (CDTX)
Postoperative pain management with acetaminophen	Cidara Therapeutics, Inc. (CDTX)
Postoperative pain management with dexketoprofen	Cidara Therapeutics, Inc. (CDTX)
Postoperative pain management with metamizole	Cidara Therapeutics, Inc. (CDTX)

Compare drugs

acam2000 vs acetazolamide acam2000 vs alendronate acam2000 vs aponvie

Frequently asked questions

How many drugs are in development for Prevention?

BioSniper tracks 114 drugs in development for Prevention across 73 companies.

How many clinical trials target Prevention?

There are 1 clinical trial targeting Prevention tracked by BioSniper.

Deep-dive into Prevention

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis